Reduced Intensity Hematopoietic-cell Transplantation in Older Patients with AML/MDS: Umbilical Cord Blood is a Feasible Option for Patients without HLA-matched Sibling Donors

Umbilical cord blood (UCB) has increased access to hematopoietic-cell transplantation (HCT) for patients without HLA-matched sibling donors (MSD). We compared outcomes of HCT using MSD (N=38) or UCB (N=60) among older patients (age ≥55 years) with acute myeloid leukemia (AML) or myelodysplastic synd...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Majhail, Navneet S, Brunstein, Claudio G, Shanley, Ryan, Sandhu, Karamjeet, McClune, Brian, Oran, Betul, Warlick, Erica D, Wagner, John E, Weisdorf, Daniel J
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4107640/
https://ncbi.nlm.nih.gov/pubmed/21602900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2011.114
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires